Streetbeat News

Stock Prices

CPSH

CPS Technologies shares are trading higher following the release of their Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:32 pm

ITRI

Itron (NASDAQ:ITRI) reported strong Q3 2024 results, with adjusted EPS of $1.84 beating estimates by 62.83% and sales of $615.46M surpassing expectations by 3.27%. This marks significant growth compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:31 pm

IDCC

InterDigital reported its Q3 2024 financial results, significantly surpassing analyst expectations. The company achieved an adjusted EPS of $1.63, beating the estimate of $0.24, and sales of $128.679 million, exceeding the expected $95.952 million.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:31 pm

SPY

The USA's personal spending for September increased by 0.5%, surpassing the estimated 0.4% and the previous month's 0.3%.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:31 pm

LICY

Li-Cycle shares rose following the announcement of an agreement with Glencore.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:30 pm

SPY

The USA Core PCE Price Index for September matched expectations at 0.3%, slightly higher than the previous month's 0.2%. This indicates stable inflation trends, which could influence market sentiment and investor decisions.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:30 pm

SPY

The Core PCE Price Index for September increased by 2.7% year-over-year, slightly above the estimated 2.6%. This indicates a modest rise in inflation, which could influence market expectations regarding interest rates and economic growth.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:30 pm

SPY

The latest report on initial jobless claims in the USA shows a decrease to 216,000, compared to the estimated 229,000 and the previous 228,000. This indicates a stronger labor market than expected.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:30 pm

AME

AMETEK shares rose following the company's announcement of better-than-expected Q3 adjusted EPS results and an optimistic FY24 adjusted EPS guidance.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:29 pm

HOWL

Werewolf Therapeutics has announced a new development candidate, WTX-921, an IL-10 INDUKINE molecule for treating inflammatory diseases like IBD. This expands their pipeline beyond oncology, showcasing their PREDATOR® platform's potential in diverse medical areas.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:29 pm